GlassScriptPhysician profile
Henry S Sun
NPI 1609845817
$20,938.17
in general payments reported to CMS, 2019-2025
39 companies · $2,622 in 2025
The $2,622 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,778 · 2020: $2,650 · 2021: $511 · 2022: $2,826 · 2023: $6,377 · 2024: $2,173 · 2025: $2,622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,943 · Travel and Lodging: $2,180 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,942.96 |
| Travel and Lodging | $2,179.53 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,608.46 | 2019-2025 | Optis, Dragonfly Opstar, Xience Skypoint |
| Boston Scientific Corporation | $3,788.10 | 2019-2025 | Avvigo Guidance System, Synergy, General - Crm_crm |
| Medtronic Vascular, INC. | $2,077.89 | 2019-2020 | |
| Inari Medical, INC. | $1,636.20 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Edwards Lifesciences Corporation | $872.89 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $548.33 | 2019-2025 | Impella |
| Janssen Pharmaceuticals, INC | $529.90 | 2019-2023 | Xarelto |
| Medtronic, INC. | $433.19 | 2021-2025 | Micra, Reveal Linq, Telescope |
| Novartis Pharmaceuticals Corporation | $295.37 | 2019-2025 | |
| Pfizer INC. | $271.43 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $271.22 | 2023-2025 | Assure Wcd |
| Shockwave Medical, INC | $245.65 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $230.34 | 2022-2025 | Lifevest |
| Stryker Corporation | $225.36 | 2025 | Flowtriever, Clottriever Bold Catheter, Flowstasis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $214.05 | 2019-2025 | Jardiance |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $212.11 | 2019-2025 | Camzyos |
| Amgen INC. | $183.36 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $158.14 | 2019-2023 | Farxiga |
| Teleflex LLC | $155.94 | 2019-2025 | Guideliner |
| Cvrx, INC. | $138.05 | 2025 | Barostim Neo System |
| Atricure, INC. | $126.30 | 2019-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Astellas Pharma US INC | $119.99 | 2024 | Padcev |
| Sanofi-Aventis U.S. LLC | $97.77 | 2019-2020 | |
| Cardiovascular Systems INC. | $77.27 | 2019 | |
| Gilead Sciences, INC. | $74.00 | 2019 | |
| Biotronik INC. | $47.28 | 2019-2022 | |
| Philips North America LLC | $46.83 | 2022-2024 | (6572) Rotational |
| Regeneron Healthcare Solutions, INC. | $42.90 | 2019 | |
| Terumo Medical Corporation | $39.56 | 2019-2025 | Tr Band, Glidesheath Slender, Metacross Otw |
| Alnylam Pharmaceuticals INC. | $25.20 | 2023 | Onpattro |
| Kiniksa Pharmaceuticals, LTD. | $22.76 | 2023 | Arcalyst |
| Lantheus Medical Imaging, INC. | $19.99 | 2019 | |
| Cardinal Health 200 LLC | $16.60 | 2021 | |
| Esperion Therapeutics, INC. | $15.78 | 2020 | |
| Merck Sharp & Dohme LLC | $15.59 | 2021 | |
| Ge Healthcare | $14.98 | 2019 | |
| Amarin Pharma, INC. | $14.14 | 2019 | |
| Irhythm Technologies, INC. | $13.73 | 2020 | |
| Bardy Diagnostics, INC. | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Sun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.